Q2 2021
Released Jul 28, 2021, after the close
10-Q filed Jul 29, 2021, 29 days after period end · 0001653477-21-000053
Q2 2021 · 10-Q
Revenue$358.40M$358.40M +32.4% vs Q2 2020+11.9% vs Q1 2021
Net Income$44.30M$44.30M +119.3% vs Q2 2020−9.0% vs Q1 2021
EPS Diluted$1.10$1.10 +124.5% vs Q2 2020−8.3% vs Q1 2021
Gross Profit$139,800,000+66.6%
Operating Income$117,700,000+75.1%
Operating Cash Flowderived$65,800,000+34.6%
Free Cash Flowderived$41,900,000+23.6%
Margins · derived
Gross margin39.0%+8.0 pt vs Q2 2020
Operating margin32.8%+8.0 pt vs Q2 2020
Net margin12.4%+4.9 pt vs Q2 2020
What the release said
The release
Same quarter
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $358.40M | $270.60M | $352.80M | $308.60M |
| Net Income | $44.30M | $20.20M | $56.80M | $46.70M |
| EPS Diluted | $1.10 | $0.49 | $1.34 | $1.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR